Design, synthesis, and evaluation of α-methylene-γ-butyrolactone analogues and their evaluation as anticancer agents is described. SAR identified a spirocyclic analogue 19 that inhibited TNFα-induced NF-κB activity, cancer cell growth and tumor growth in an ovarian cancer model. A second iteration of synthesis and screening identified 29 which inhibited cancer cell growth with low-μM potency. Our data suggest that an isatin-derived spirocyclic α-methylene-γ-butyrolactone is a suitable core for optimization to identify novel anticancer agents.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273401 | PMC |
| http://dx.doi.org/10.1021/acs.jmedchem.6b00400 | DOI Listing |
Publication Analysis
Top Keywords
anticancer agents
12
cancer cell
8
cell growth
8
isatin derived
4
derived spirocyclic
4
spirocyclic analogues
4
analogues α-methylene-γ-butyrolactone
4
α-methylene-γ-butyrolactone anticancer
4
agents structure-activity
4
structure-activity relationship
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!